Neurocrine Biosciences Inc (NBIX)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 412M | 420.4M | 452.7M | 498.8M | 515.2M | 515.3M | 590.2M | 622.1M |
| Operating Income | 103.4M | -114.2M | 73.6M | 141.2M | 150.3M | 99.3M | 145.4M | 183.8M |
| Pre Tax Income | 117.9M | -103.3M | 121.6M | 115.6M | 198.2M | 34.5M | 98.6M | 190.3M |
| Net Income | 89M | -76.6M | 95.5M | 83.1M | 147.7M | 43.4M | 65M | 129.8M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 103.4M | -114.2M | 73.6M | 141.2M | 150.3M | 10.6M | 145.4M | 183.8M |
| EBITDA | 107.3M | -109.2M | 78.7M | 146.7M | 156M | 105.5M | 152.7M | 190.3M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 15M | 161.63M | 451.24M | 788.09M | 1.05B | 1.13B | 1.49B | 1.89B |
| Operating Income | -147.37M | -131.36M | 36.9M | 72.28M | 163M | 102.5M | 249M | 250.9M |
| Pre Tax Income | -141.09M | -142.54M | 21.84M | 46.54M | 106.7M | 101.4M | 213.9M | 332.1M |
| Net Income | -141.09M | -142.54M | 21.11M | 37.01M | 407.3M | 89.6M | 154.5M | 249.7M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -1.624 | -1.605 | 0.233 | 0.401 | 4.356 | 0.944 | 1.601 | 2.541 |
| EBIT | -143.93M | -129.26M | 36.9M | 59.3M | 126.9M | 102.5M | 249M | 250.9M |
| EBITDA | -145.87M | -128.96M | 40.92M | 79.74M | 171.6M | 113.4M | 264.1M | 272.2M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
